Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene

Journal Title: Turkish Journal of Hematology - Year 2015, Vol 32, Issue 3

Abstract

Authors and Affiliations

Fatih Demircioğlu, Mustafa Erkoçoğlu, Mervan Bekdaş, Sevil Göksügür, Semra Büyükkorkmaz, Seher Açar

Keywords

Related Articles

Hb D-Los Angeles [beta121(GH4)Glu>Gln] and Hb Beograd [beta121(GH4)Glu>Val]: Implications for their laboratory diagnosis and genetic origins

Objective: The aim of this study was to determine the laboratory diagnosis and genetic origins of the hemoglobin (Hb) variants, Hb D-Los Angeles and Hb Beograd observed frequently in our region. Material and Methods: Hb...

Clinical Trials in Turkey

Turkey is an emerging economy in almost all sectors, and especially in pharmaceuticals. Turkey has had clinical trial legislation for a long time. There are also clinical trial regulations and guidelines. Turkey has take...

Download PDF file
  • EP ID EP95294
  • DOI 10.4274/tjh.2014.0478
  • Views 94
  • Downloads 0

How To Cite

Fatih Demircioğlu, Mustafa Erkoçoğlu, Mervan Bekdaş, Sevil Göksügür, Semra Büyükkorkmaz, Seher Açar (2015). Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene. Turkish Journal of Hematology, 32(3), 283-284. https://europub.co.uk/articles/-A-95294